1 asset in Neuromuscular Disease Caused By Qualitative Or Quantitative Defects Of Dystrophin

Therapeutic assets addressing Neuromuscular Disease Caused By Qualitative Or Quantitative Defects Of Dystrophin, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Zeleciment Rostudirsen Neuromuscular Disease Caused By Qualitative Or Quantitative Defects Of Dystrophin	Dyne Therapeutics	P3	B (60)